Olive Leaf Extracts With High, Medium, or Low Bioactive Compounds Content Differentially Modulate Alzheimer's Disease via Redox Biology
Food Frontiers · 2025-05 · 6 (3) · 1513-1529
DOI: 10.1002/fft2.70013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food Frontiers, online erschienen am 02.04.2025. Verfasst von Jose M. Romero‐Marquez und 12 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) involves β‐amyloid plaques and tau hyperphosphorylation, driven by oxidative stress and neuroinflammation. Cyclooxygenase‐2 (COX‐2) and acetylcholinesterase (AChE) activities exacerbate AD pathology. Olive leaf (OL) extracts, rich in bioactive compounds, offer potential therapeutic benefits. This study aimed to assess the anti‐inflammatory, anti‐cholinergic, and antioxidant effects of three OL extracts (low, mid, and high bioactive content) in vitro and their protective effects against AD‐related proteinopathies in Caenorhabditis elegans models. OL extracts were characterized for phenolic composition, AChE and COX‐2 inhibition, as well as antioxidant capacity. Their effects on intracellular and mitochondrial reactive oxygen species (ROS) were tested in C. elegans models expressing human Aβ and tau proteins. Gene expression analyses examined transcription factors (DAF‐16, skinhead [SKN]‐1) and their targets (superoxide dismutase [SOD]‐2, SOD‐3, GST‐4, and heat shock protein [HSP]‐16.2). High‐OL extract demonstrated superior AChE and COX‐2 inhibition and antioxidant capacity. Low‐ and high‐OL extracts reduced Aβ aggregation, ROS levels, and proteotoxicity via SKN‐1/NRF‐2 and DAF‐16/FOXO pathways, whereas mid‐OL showed moderate effects through proteostasis modulation. In tau models, low‐ and high‐OL extracts mitigated mitochondrial ROS levels via SOD‐2 but had limited effects on intracellular ROS levels. High‐OL extract also increased GST‐4 levels, whereas low and mid extracts enhanced GST‐4 levels. OL extracts protect against AD‐related proteinopathies by modulating oxidative stress, inflammation, and proteostasis. High‐OL extract showed the most promise for nutraceutical development due to its robust phenolic profile and activation of key antioxidant pathways. Further research is needed to confirm long‐term efficacy.
Zitieren
APA
Romero‐Marquez, J. M., Navarro‐Hortal, M. D., Varela‐López, A., Calderón‐Iglesias, R., Puentes, J. G., Giampieri, F., Battino, M., Sánchez‐González, C., Xiao, J., García‐Ruiz, R., Sánchez, S., Forbes‐Hernández, T. Y., & Quiles, J. L. (2025). Olive Leaf Extracts With High, Medium, or Low Bioactive Compounds Content Differentially Modulate Alzheimer's Disease via Redox Biology. Food Frontiers, 6(3), 1513-1529. https://doi.org/10.1002/fft2.70013
Vancouver
Romero‐Marquez JM, Navarro‐Hortal MD, Varela‐López A, Calderón‐Iglesias R, Puentes JG, Giampieri F, et al. Olive Leaf Extracts With High, Medium, or Low Bioactive Compounds Content Differentially Modulate Alzheimer's Disease via Redox Biology. Food Frontiers. 2025;6(3):1513-1529. doi:10.1002/fft2.70013
BibTeX
@article{RomeroMarquez2025,
author = {Romero‐Marquez, Jose M. and Navarro‐Hortal, María D. and Varela‐López, Alfonso and Calderón‐Iglesias, Rubén and Puentes, Juan G. and Giampieri, Francesca and Battino, Maurizio and Sánchez‐González, Cristina and Xiao, Jianbo and García‐Ruiz, Roberto and Sánchez, Sebastián and Forbes‐Hernández, Tamara Y. and Quiles, José L.},
title = {Olive Leaf Extracts With High, Medium, or Low Bioactive Compounds Content Differentially Modulate Alzheimer's Disease via Redox Biology},
journal = {Food Frontiers},
year = {2025},
volume = {6},
number = {3},
pages = {1513--1529},
doi = {10.1002/fft2.70013}
}
EUVIMED